肿瘤患者衰弱评估工具应用的范围综述

李垚; 陈小敏; 夏敏; 吴茜; 张琳; 陈叡喆; 葛莉丽; 吴逸梅

doi:10.16460/j.issn1008-9969.2025.04.048

PDF(711 KB)

护理学报 ›› 2025, Vol. 32 ›› Issue (4) : 48-52. DOI: 10.16460/j.issn1008-9969.2025.04.048

循证护理

肿瘤患者衰弱评估工具应用的范围综述

李垚^1a,2, 陈小敏³, 夏敏³, 吴茜^1a, 张琳^1b, 陈叡喆³, 葛莉丽³, 吴逸梅³

作者信息 +

文章历史 +

摘要

目的全面系统地收集国内外用于评估肿瘤患者衰弱的工具,总结分析工具的基本特征,为医护人员选择肿瘤患者衰弱评估工具提供参考。方法系统检索9个数据库（Web of Science、PubMed、CINAHL Complete、EMBASE、Cochrane Library、SinoMed、中国知网、万方数据库、中华医学期刊全文数据库）,检索时限为建库至2023年12月20日。提取肿瘤患者衰弱评估工具相关研究进行系统分析,并通过范围综述对检索结果形成规范化报告。结果最终检索出16 819篇中英文文献,纳入17篇符合标准的文献。筛选出18种应用于肿瘤患者的衰弱评估工具。结论现阶段常见18种衰弱评估工具应用在肿瘤领域9个病种,半数以上呈现出较好的评估效用,根据患者特征及应用需求选择适合工具,目前尚无肿瘤衰弱评估统一标准。

关键词

肿瘤 / 肿瘤衰弱 / 评估工具 / 范围综述

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用

李垚, 陈小敏, 夏敏, 吴茜, 张琳, 陈叡喆, 葛莉丽, 吴逸梅. 肿瘤患者衰弱评估工具应用的范围综述[J]. 护理学报. 2025, 32(4): 48-52 https://doi.org/10.16460/j.issn1008-9969.2025.04.048

中图分类号： R473.73

参考文献

[1] Maeda H, Takahashi M, Seo S, et al.Frailty and colorectal surgery: review and concept of cancer frailty[J]. J Clin Med,2023,12(15):5041. DOI: 10.3390/jcm12155041.
[2] Handforth C, Clegg A, Young C, et al.The prevalence and outcomes of frailty in older cancer patients: a systematic review[J]. Ann Oncol, 2015,26(6):1091-1101.DOI:10.1093/annonc /mdu540.
[3] Gillis C, Li C, Lee L, et al.Prehabilitation versus rehabilitation: a randomized control trial in patients undergoing colorectal resection for cancer[J]. Anesthesiology, 2014,121(5):937-947. DOI: 10.1097/ALN.0000000000000393.
[4] Lee HS, Lee J, Jo JC, et al.Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population[J]. Sci Rep,2021,11(1):22907. DOI: 10.1038/s41598-021-02433-6.
[5] Arksey H, O’ Malley L .Scoping studies: towards a methodological framework[J]. Int J Soc Res Methodol, 2005, 8(1):19-32. DOI:10.1080/1364557032000119616.
[6] Daudt HM, Van Mossel C, Scott SJ.Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework[J].BMC Med Res Methodol, 2013,13:48. DOI:10.1186/1471-2288-13-48.
[7] Terwee CB, Bot SD, De Boer MR, et al.Quality criteria were proposed for measurement properties of health status questionnaires[J]. [J] Clin Epidemiol. 2007,60(1):34-42. DOI: 10.1016/j.jclinepi.2006.03.012.
[8] Cooper L, Deeb A, Dezube AR, et al.Validation of the Pictorial Fit-Frail Scale (PFFS) in a thoracic surgery clinic[J]. Ann Surg, 2023, 277(5):e1150-e1156. DOI:10.1097/SLA.000000 0000005381.
[9] 张琴,於茗,王慧,等. 4种衰弱识别工具在老年癌症患者中的应用比较[J]. 护理学杂志,2023,38(15):92-96. DOI:10.3870/j.issn.1001-4152.2023.15.092.
[10] Zhao H, Lu X, Zheng S, et al.Comparison of two frailty screening tools in older patients with colorectal cancer[J]. BMC Geriatr, 2023, 23(1):295. DOI:10.1186/s12877-023-03974-3.
[11] Semsar-Kazerooni K, Richardson K, Forest VI, et al.Development and validation of the Modified Index of Fragility (mIFG) in head and neck cancer surgery[J]. J Otolaryngol Head Neck Surg,2023,52(1):5. DOI: 10.1186/s40463-022-00607-4.
[12] Ding L, Miao X, Lu J, et al.Comparing the Performance of Different Instruments for diagnosing frailty and predicting adverse outcomes among elderly patients with gastric cancer[J]. J Nutr Health Aging,2021,25(10):1241-1247. DOI: 10.1007/s12603-021-1701-8.
[13] Chen SY, Chou WC, Lin YC, et al.Performance of two frailty screening tools among patients with cancer in Taiwan[J]. Biomed J,2022,45(2):361-369. DOI:10.1016/j.bj.2021.03.00 2.
[14] Nishijima TF, Shimokawa M, Esaki T, et al.A 10-Item Frailty Index Based on a Comprehensive Geriatric Assessment (FI-CGA-10) in older adults with cancer: development and construct validation[J]. Oncologist, 2021,26(10):e1751-e1760. DOI: 10.1002/onco.13894.
[15] Kenig J, Szabat K, Mitu J,et al.Usefulness of eight screening tools for predicting frailty and postoperative short- and long-term outcomes among older patients with cancer who qualify for abdominal surgery[J]. Eur J Surg Oncol,2020,46(11):2091-2098.DOI:10.1016/j.ejso.2020.07. 040.
[16] Bruijnen CP, Heijmer A, van Harten-Krouwel DG, et al. Validation of the G8 screening tool in older patients with cancer considered for surgical treatment[J]. J Geriatr Oncol,2021,12(5):793-798. DOI: 10.1016/j.jgo.2020.10.017.
[17] Orlandini L, Nestola T, Colloca GF, et al.The Frailty Index(FI) in older women with gynecological cancer[J]. Aging Clin Exp Res,2020,32(8):1561-1565.DOI:10.1007/s40520-02 0-01473-8.
[18] Bréchemier D, Sourdet S, Girard P, et al.Use of Comprehensive Geriatric Assessment(CGA) to define frailty in geriatric oncology: Searching for the best threshold. Cross-sectional study of 418 old patients with cancer evaluated in the Geriatric Frailty Clinic (G.F.C.) of Toulouse (France)[J]. J Geriatr Oncol,2019,10(6):944-950. DOI: 10.1016/j.jgo.2019.03.011.
[19] Shahrokni A, Tin A, Alexander K, et al.Development and evaluation of a new frailty index for older surgical patients with cancer[J]. JAMA Netw Open,2019,2(5):e193545. DOI: 10.1001/jamanetworkopen.2019.3545.
[20] McCarthy AL, Peel NM, et al. Validation of a Frailty Index (FI) in older cancer patients with solid tumours[J]. BMC Cancer, 2018,18(1):892.DOI:10.1186/s12885-018-4807-6.
[21] Meyers BM, Al-Shamsi HO, Rask S, et al.Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during treatment of colorectal cancer[J]. J Gastrointest Oncol,2017,8(1):32-38. DOI: 10.21037/jgo.2016.11.12.
[22] De la Garza Ramos R, Goodwin CR, et al. Development of a Metastatic Spinal Tumor Frailty Index (MSTFI) using a nationwide database and its association with inpatient morbidity, mortality,length of stay after spine surgery[J].World Neurosurg,2016,95:548-555.e4. DOI:10.1016 /j.wneu. 2016.08.029.
[23] Smets IH, Kempen GI, Janssen-Heijnen ML, et al.Four screening instruments for frailty in older patients with and without cancer: a diagnostic study[J]. BMC Geriatr,2014,14:26. DOI: 10.1186/1471-2318-14-26.
[24] Townsend M, Kallogjeri D, Scott-Wittenborn N, et al.Multidisciplinary clinic management of head and neck cancer[J]. JAMA Otolaryngol Head Neck Surg, 2017, 143(12):1213-1219. DOI: 10.1001/jamaoto.2017.1855.
[26] 毛欣楠,徐林燕,赵磊,等. 医院衰弱风险评分在老年住院患者不良结局预测中的应用进展[J].护理学报,2022,29(24):18-21.DOI:10.16460/j.issn1008-9969.2022.24.018.
[27] Zhang Q, Wang L, Zhang S, et al.Cross-cultural adaptation and validation of the Geriatric 8(G-8) screening tool in Chinese hospitalized older adults with cancer[J]. Geriatr Nurs,2023,49:22-29. DOI: 10.1016/j.gerinurse.
[28] Theou O, Andrew M, Ahip SS, et al.The Pictorial Fit-Frail Scale: developing a visual scale to assess frailty[J]. Can Geriatr J,2019,22(2):64-74. DOI:10.5770/cgj.22.357.
[29] Cheng JJ, Tooze JA, Callahan KE,et al.Assessment of an embedded primary care-derived electronic health record (EHR) frailty index (eFI) in older adults with acute myeloid leukemia[J]. J Geriatr Oncol, 2023,14(7):101509.DOI:10.1016/j.jgo.2023.101509.
[30] Bentsen KK, Hansen O, Ryg J, et al.Combination of the G-8 screening tool and Hand-Grip Strength to predict long-term overall survival innon-small cell lung cancer patients undergoing stereotactic body radiotherapy[J].Cancers (Basel),2021,13(13):3363.DOI:10.3390/cancers131 33363.
[31] Bessems SAM, Konsten JLM, Vogelaar JFJ, et al.Frailty screening by Geriatric-8(G-8) and 4-meter gait speed test is feasible and predicts postoperative complications in elderly colorectal cancer patients[J].J Geriatr Oncol,2021,12(4):592-598.DOI: 10.1016/j.jgo.2020.10.012.
[32] U.S.Department of Health and Human Services FDA Center for Drug Evaluation and Research,U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance[J]. Health Qual Life Outcomes,2006,4:79. DOI:10.1186/1477-7525-4-79.
[33] Handforth C, Clegg A, Young C, et al.The prevalence and outcomes of frailty in older cancer patients: a systematic review[J]. Ann Oncol,2015,26(6):1091-1101. DOI:10.1093/annonc/mdu540.